株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

バイオマーカー研究サービスの世界市場:市場規模、シェア、見通し、市場機会の分析 2018年~2026年

Biomarker Research Services Market - Size, Share, Outlook, and Opportunity Analysis, 2018-2026

発行 Coherent Market Insights 商品コード 865087
出版日 ページ情報 英文 178 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.62円で換算しております。
Back to Top
バイオマーカー研究サービスの世界市場:市場規模、シェア、見通し、市場機会の分析 2018年~2026年 Biomarker Research Services Market - Size, Share, Outlook, and Opportunity Analysis, 2018-2026
出版日: 2019年05月11日 ページ情報: 英文 178 Pages
概要

精密医療の開発に関するイニシアチブや、慢性疾患の有病率の上昇などによって世界のバイオマーカー研究サービス市場の成長が促進されています。

当レポートでは、世界のバイオマーカー研究サービス市場を調査し、市場の概要、サービスタイプ・適応症・地域別の市場規模の推移と予測、市場の成長要因および阻害要因の分析、市場機会、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 調査目的と仮定

  • 調査目的
  • 仮定
  • 略語

第2章 市場の範囲

  • レポート概要
    • 市場の定義と範囲
  • エグゼクティブサマリー
    • 市場スニペット:サービスタイプ別
    • 市場スニペット:適応症別
    • 市場スニペット:地域別
  • コヒーレントオポチュニティマップ(COM)

第3章 市場力学、規制、動向分析

  • 市場力学
    • 成長要因
    • 阻害要因
    • 市場機会
  • 影響分析
  • 米国FDA認定バイオマーカー
  • 規制シナリオ
  • 米国FDAバイオマーカー認定プログラム
  • 主なハイライト
  • 合同研究開発・合併・買収
  • PEST分析
  • バイオマーカー開発および試験技術
  • バイオマーカー開発パイプライン
  • 疫学

第4章 世界のバイオマーカー研究サービス市場:サービスタイプ別

  • イントロダクション
  • バイオマーカー研究サービス
  • コンパニオン診断(CDx)研究サービス

第5章 世界のバイオマーカー研究サービス市場:適応症別

  • イントロダクション
  • 腫瘍
  • 心血管疾患
  • 感染症
  • 神経疾患
  • 免疫疾患
  • その他

第6章 世界のバイオマーカー研究サービス市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • 中南米
  • アフリカ
  • 中東

第7章 競争環境

  • ヒートマップ解析
  • 企業プロファイル
    • Noble Life Sciences, Inc.
    • REPROCELL Corporation
    • Coriell Institute
    • BioIVT
    • ICON Plc.
    • SRI International
    • Charles River Laboratories, Inc.
    • Nordic Bioscience A/S
    • Proteome Sciences Plc.
    • Covance Inc.

第8章 セクション

  • 参考文献
  • 調査方法
  • Coherent Market Insightsについて
目次

Biomarkers are widely used in development of drugs. One of the primary processes through which biomarkers are accepted for use in drug development, is the drug approval process. The biomarker is included in the regulatory submission process for drug approval such as Investigational New Drug (IND), Biologics License Disease Indications (BLA), or New Drug Disease Indication (NDA), and are then accepted for use in that specific drug development program. Another process through which biomarkers are accepted for use in drug development is the Biomarker Qualification Program (BQP), which qualifies a biomarker for a particular context of use (COU), independent of a drug approval submission. This pathway is intended for biomarkers that are used in multiple drug development programs. Qualified biomarkers have the potential to offer valuable information that may help during drug development.

Market Dynamics

Factors such as increasing initiatives for development of precision medicine, increasing prevalence of chronic diseases, and increasing demand for development of companion diagnostics, is supporting the growth of global biomarker research services market. For instance, in 2017, National Institutes of Health launched Precision Medicine Initiative (PMI) with an investment of US$ 215 million to accelerate biomedical research and offer clinicians new tools to select therapies that can be used in a more individualized approach with patients. Moreover, potential of biomarkers in disease diagnosis, and in companion diagnostics is expected to boost global biomarker research services market growth. Organizations such as Covance, Inc., Charles River, and others are actively involved in providing biomarker research services.

Key features of the study:

  • This report provides in-depth analysis of global biomarker research services market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018-2026), considering 2017 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights into market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global biomarker research services market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key companies covered as a part of this study include Noble Life Sciences, Inc., Reprocell Corporation, Coriell Institute, BioIVT, ICON Plc., SRI International, Inc., Charles River Laboratories, Inc., Nordic Bioscience A/S, Proteome Sciences Plc., and Covance Inc. (Laboratory Corporation of America Holdings, Inc.)
  • Insights from this report would allow marketers and management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global biomarker research services market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the global biomarker research services market

Detailed Segmentation:

  • Global Biomarker Research Services Market, By Service Type:
    • Biomarker Research Services
    • CDx Research Services
  • Global Biomarker Research Services Market, By Disease Indication:
    • Oncology
    • Cardiovascular Disorder
    • Infectious Disease
    • Neurological Disorder
    • Immunological Disorder
    • Others
  • Global Biomarker Research Services Market, By Region:
    • North America
      • By Service Type:
      • Biomarker Research Services
      • CDx Research Services
      • By Disease Indication:
      • Oncology
      • Cardiovascular Disorder
      • Infectious Disease
      • Neurological Disorder
      • Immunological Disorder
      • Others
      • By Country:
      • U.S.
      • Canada
    • Europe
      • By Service Type:
      • Biomarker Research Services
      • CDx Research Services
      • By Disease Indication:
      • Oncology
      • Cardiovascular Disorder
      • Infectious Disease
      • Neurological Disorder
      • Immunological Disorder
      • Others
      • By Country:
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Service Type:
      • Biomarker Research Services
      • CDx Research Services
      • By Disease Indication:
      • Oncology
      • Cardiovascular Disorder
      • Infectious Disease
      • Neurological Disorder
      • Immunological Disorder
      • Others
      • By Country:
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
    • Latin America
      • By Service Type:
      • Biomarker Research Services
      • CDx Research Services
      • By Disease Indication:
      • Oncology
      • Cardiovascular Disorder
      • Infectious Disease
      • Neurological Disorder
      • Immunological Disorder
      • Others
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Middle East
      • By Service Type:
      • Biomarker Research Services
      • CDx Research Services
      • By Disease Indication:
      • Oncology
      • Cardiovascular Disorder
      • Infectious Disease
      • Neurological Disorder
      • Immunological Disorder
      • Others
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Service Type:
      • Biomarker Research Services
      • CDx Research Services
      • By Disease Indication:
      • Oncology
      • Cardiovascular Disorder
      • Infectious Disease
      • Neurological Disorder
      • Immunological Disorder
      • Others
      • By Country/Region:
      • Central Africa
      • South Africa
      • North Africa
  • Company Profiles
    • Noble Life Sciences, Inc.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
    • REPROCELL Corporation
    • Coriell Institute
    • BioIVT
    • ICON Plc.
    • SRI International
    • Charles River Laboratories, Inc.
    • Nordic Bioscience A/S
    • Proteome Sciences Plc.
    • Covance Inc. (Laboratory Corporation of America Holdings, Inc.)

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Service Type
    • Market Snippet, By Disease Indication
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Qualified Biomarkers By U.S. FDA
  • Regulatory Scenario
  • U.S. FDA Biomarker Qualification Program
  • Key Highlights
  • Research and Development Collaboration, Mergers, and Acquisitions
  • PEST Analysis
  • Biomarker Development and Testing Technologies
  • Biomarker Development Pipeline
  • Epidemiology

4. Global Biomarker Research Services Market, By Service Type, 2016-2026 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2017 and 2026 (%)
    • Y-o-Y Growth Analysis, 2018-2026
    • Segment Trends
  • Biomarker Research Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
  • Companion Diagnostics (CDx) Research Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)

5. Global Biomarker Research Services Market, By Disease Indication, 2016-2026 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2017 and 2026 (%)
    • Y-o-Y Growth Analysis, 2018-2026
    • Segment Trends
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
  • Cardiovascular Disorder
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
  • Infectious Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
  • Neurological Disorder
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
  • Immunological Disorder
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)

6. Global Biomarker Research Services Market, By Regions, 2016-2026 (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2017 and 2026 (%)
    • Y-o-Y Growth Analysis, For Regions, 2018-2026
  • North America
    • Market Size and Forecast, By Service Type, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016-2026 (US$ Mn)
    • U.S.
    • Canada
  • Europe
    • Market Size and Forecast, By Service Type, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016-2026 (US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Service Type, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016-2026 (US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Market Size and Forecast, By Service Type, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016-2026 (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Service Type, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016-2026 (US$ Mn)
    • Central Africa
    • South Africa
    • North Africa
  • Middle East
    • Market Size and Forecast, By Service Type, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016-2026 (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East

7. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • Noble Life Sciences, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • REPROCELL Corporation
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Coriell Institute
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • BioIVT
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • ICON Plc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • SRI International
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Charles River Laboratories, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Nordic Bioscience A/S
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Proteome Sciences Plc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Covance Inc. (Laboratory Corporation of America Holdings, Inc.)
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

8. Section

  • References
  • Research Methodology
  • About us and Sales Contact
Back to Top